Gene · 5885
Papers3,897
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,897
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| N-Acryloylindole-alkyne (NAIA) enables imaging and profiling new ligandable cysteines and oxidized thiols by chemoproteomics. | Nat Commun | 2023 | 37322008 | PubTator, text mining | PubMed |
| Specific blood monocyte distribution in histiocytoses correlates with vascular involvement and disease activity. | Haematologica | 2023 | 37317872 | PubTator, text mining | PubMed |
| Var∣Decrypt: a novel and user-friendly tool to explore and prioritize variants in whole-exome sequencing data. | Epigenetics Chromatin | 2023 | 37312221 | PubTator, text mining | PubMed |
| H4K16ac activates the transcription of transposable elements and contributes to their cis-regulatory function. | Nat Struct Mol Biol | 2023 | 37308596 | PubTator, text mining | PubMed |
| Oculofaciocardiodental syndrome caused by a novel BCOR variant. | Hum Genome Var | 2023 | 37308473 | PubTator, text mining | PubMed |
| The histone methyltransferase NSD3 contributes to sister chromatid cohesion and to cohesin loading at mitotic exit. | J Cell Sci | 2023 | 37288770 | PubTator, text mining | PubMed |
| Use of whole genome sequencing to determine the genetic basis of visceral myopathies including Prune Belly syndrome. | J Rare Dis (Berlin) | 2023 | 37288276 | PubTator, text mining | PubMed |
| Comprehensive multiomics analyses reveal pervasive involvement of aberrant cohesin binding in transcriptional and chromosomal disorder of cancer cells. | iScience | 2023 | 37283809 | PubTator, text mining | PubMed |
| Crossover interference mechanism: New lessons from plants. | Front Cell Dev Biol | 2023 | 37274744 | PubTator, text mining | PubMed |
| The EstroGene Database Reveals Diverse Temporal, Context-Dependent, and Bidirectional Estrogen Receptor Regulomes in Breast Cancer. | Cancer Res | 2023 | 37272757 | PubTator, text mining | PubMed |
| Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis. | Elife | 2023 | 37267125 | PubTator, text mining | PubMed |
| Transcriptomic analysis of neutrophil apoptosis induced by diffuse large B-cell lymphoma unveils a potential role in neutropenia. | Genes Genomics | 2023 | 37266765 | PubTator, text mining | PubMed |
| Enhancer RNAs in transcriptional regulation: recent insights. | Front Cell Dev Biol | 2023 | 37266452 | PubTator, text mining | PubMed |
| Multiomic analysis of cohesin reveals that ZBTB transcription factors contribute to chromatin interactions. | Nucleic Acids Res | 2023 | 37264934 | PubTator, text mining | PubMed |
| Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer's disease. | Nat Neurosci | 2023 | 37264161 | PubTator, text mining | PubMed |
| Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease. | Front Immunol | 2023 | 37251379 | PubTator, text mining | PubMed |
| A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer. | iScience | 2023 | 37250326 | PubTator, text mining | PubMed |
| A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide. | Pharmaceuticals (Basel) | 2023 | 37242424 | PubTator, text mining | PubMed |
| DNA Repair Pathway in Ovarian Cancer Patients Treated with HIPEC. | Int J Mol Sci | 2023 | 37240218 | PubTator, text mining | PubMed |
| Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancer. | Heliyon | 2023 | 37234659 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5885/papers?page=22